Hidden Toll: Study Suggests UK Synthetic Opioid Deaths May Be Significantly Underreported
Deaths linked to a powerful class of synthetic opioids may be substantially higher than official figures indicate, according to new research from the United Kingdom. Scientists warn that fatalities involving nitazenes—extremely potent synthetic opioids—could be underestimated by as much as one-third due to limitations in current toxicology testing methods.
Nitazenes are synthetic opioids developed in the 1950s as potential painkillers. However, their development was abandoned because of their extraordinary potency and high risk for addiction. Some compounds in this class are estimated to be up to 500 times stronger than heroin, making even small amounts potentially lethal.
In 2024, the UK’s National Crime Agency (NCA) reported 333 deaths associated with nitazenes. But researchers at King’s College London argue that the real number may be significantly higher. Their concern centers on the possibility that nitazenes degrade in postmortem samples, leading to missed detections during routine toxicology screenings.
Why deaths may be going undetected
To investigate this issue, researchers conducted laboratory testing using rats that had been anesthetized with nitazenes. Under conditions that mimic real-world pathology and toxicology sample handling, they found that, on average, only about 14% of the original nitazene concentration remained detectable by the time testing occurred.
This degradation suggests that a large portion of the drug may no longer be measurable in postmortem blood samples, increasing the likelihood that deaths involving nitazenes are misclassified or overlooked.
The team then applied statistical modeling to data from the UK National Programme on Substance Use Mortality (NPSUM). Their analysis revealed a roughly one-third excess in drug-related deaths in Birmingham in 2023 compared to expectations. Researchers concluded that undetected nitazenes could plausibly explain this discrepancy.
Dr. Caroline Copeland, senior lecturer in pharmacology and toxicology at King’s College London and lead author of the study, emphasized the broader implications. “If a significant share of these deaths is not being properly identified, then our national mortality statistics are incomplete,” she said. “These figures directly inform harm reduction strategies and funding decisions. When the data are wrong, our response will also fall short.”
She added that if nitazenes are breaking down in postmortem blood samples, the country is likely undercounting their true impact. “We risk trying to manage a public health emergency with incomplete information,” she said. “When we fail to accurately measure the scale of the problem, preventable deaths can continue.”
Behind the statistics, Copeland noted, are families seeking answers and communities facing an expanding but largely unseen crisis driven by extremely potent synthetic opioids.
A growing public health threat
The emergence of nitazenes reflects a broader shift in the illicit drug supply toward highly potent synthetic opioids. In Scotland, public health officials have already warned of a renewed drug death crisis tied to these substances, which have been linked to more than 100 fatalities.
The potency of synthetic opioids has raised particular alarm globally, especially as drug supplies become more unpredictable and frequently contain multiple substances. Similar concerns have been raised about highly potent opioids such as FYL, as well as combinations involving other sedatives like XYL in different regions.
Mike Trace, chief executive of the Forward Trust and co-creator of the UK’s first national drug strategy, said the findings reinforce calls for stronger intervention. “The extreme strength of nitazenes has clearly contributed to rising overdoses among people who use drugs,” he said. “This research suggests official statistics may be underestimating the scale of the problem. It strengthens the case for expanding drug checking services and overdose prevention measures.”
With more than 17,000 people each year in the UK dying from drug- or alcohol-related causes, Trace argued that policymakers must act decisively to expand access to lifesaving health services.
Government response
A government spokesperson described every drug-related death as a tragedy and reaffirmed the government’s commitment to reducing fatalities and supporting recovery efforts. Officials say they remain vigilant regarding emerging drug threats and are working closely with health agencies and law enforcement to respond.
In an effort to intercept dangerous substances before they reach communities, UK Border Force has deployed specially trained detection dogs capable of identifying highly potent synthetic opioids, including FYL and nitazenes.
As the research suggests, accurately identifying and tracking these substances will be essential. Without reliable detection and reporting, public health responses may lag behind an evolving and increasingly dangerous drug landscape.
Source: The Guardian